株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

再生医療の世界市場の分析:機会と予測

Global Regenerative Medicine Market: Analysis By Type (Cell Therapy, Tissue Engineered, Gene Therapy), By Application, By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024)

発行 Azoth Analytics 商品コード 909913
出版日 ページ情報 英文 326 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
再生医療の世界市場の分析:機会と予測 Global Regenerative Medicine Market: Analysis By Type (Cell Therapy, Tissue Engineered, Gene Therapy), By Application, By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024)
出版日: 2019年08月31日 ページ情報: 英文 326 Pages
概要

当レポートでは、世界の再生医療市場について調査分析し、統計・情報 (市場規模・シェア・成長要因) のほか、新興動向、主要促進要因、課題・機会、主要企業などについて、体系的な情報を提供しています。

第1章 調査手法

第2章 エグゼクティブサマリー

第3章 戦略的提言

第4章 再生医療市場:製品の見通し

第5章 世界の再生医療市場:成長率・予測

  • 金額別 (実績)
  • 金額別 (予測)

第6章 世界の再生医療市場:セグメント別分析

  • 市場規模、タイプ別:内訳
  • 市場規模、用途別:内訳

第7章 世界の再生医療市場:地域別分析

  • 市場規模、地域別:内訳
  • 北米の再生医療市場:成長率・予測
  • 北米の再生医療市場:国別分析
  • 欧州の再生医療市場:成長率・予測
  • 欧州の再生医療市場:国別分析
  • アジア太平洋地域の再生医療市場:成長率・予測
  • アジア太平洋地域の再生医療市場:国別分析
  • その他の地域の再生医療市場:成長率・予測
  • その他の地域の再生医療市場:国別分析

第8章 世界の再生医療市場:競合情勢

第9章 世界の再生医療市場力学

  • 市場促進要因
  • 市場抑制要因
  • 市場動向

第10章 ファイブフォース分析

第11章 SWOT分析

第12章 政策・規制情勢

第13章 企業プロファイル

  • Vericel Corporation
  • Gilead Sciences
  • Novartis
  • Spark Therapeutics
  • Orchard Therapeutics
  • Shanghai Sunway Biotech Co. Ltd.
  • MolMed
  • Celgene
  • Sanofi
  • Amgen
図表

List of Figures

  • Figure 1: Global Regenerative Medicine Market Size, By Value, 2014-2018 (USD Million)
  • Figure 2: Global Regenerative Medicine Market Size, By Value, Forecast, 2019-2024 (USD Million)
  • Figure 3: Global Number of regenerative medicine Companies, By Region, 2018
  • Figure 4: Biotechnology Research and Development Services Cost Index, In 2018
  • Figure 5: Clinical trials of regenerative medicine, By Type, In number, In 2018
  • Figure 6: Clinical trials of regenerative medicine, By Application, In number, In 2018
  • Figure 7: Financing for Regenerative Medicines, By Type, In USD million, In 2018
  • Figure 8: Financing for Regenerative Medicines, By Organizations, In USD million, In 2018
  • Figure 9: Causes of premature (under age 70) NCD mortality, 2017 (%)
  • Figure 10: Number of New Cases of Cancer, In 2018, By Type, (% of Total)
  • Figure 11: Number of New Cases of Cancer, In 2018, By Region, (% of Total)
  • Figure 12: Prevalence of Diagnosed Autoimmune Diseases, In 2018, By Selected Countries, (% of Total)
  • Figure 13: Number of people with diabetes, Worldwide, (In million), 2017 & 2045E
  • Figure 14: Projected increase in cases of diabetes in 2045, By region (In Percentage)
  • Figure 15: Prevalence of musculoskeletal condition worldwide, 2013-2020E, In billion
  • Figure 16: Prevalence of cardiovascular diseases worldwide, 2013-2018, In million
  • Figure 17: Prevalence of chronic respiratory diseases worldwide, 2013-2020E, In million
  • Figure 18: Prevalence of skin diseases worldwide, 2013-2020E, In million
  • Figure 19: GDP Per Capita PPP, By Region, In 2018 (in Thousand USD)
  • Figure 20: Projected global population aged 60 years & above (In Millions)
  • Figure 21: Global Regenerative Medicine Market Size, By Type, 2018 (%)
  • Figure 22: Global Regenerative Medicine Market Size, By Type, 2024F (%)
  • Figure 23: Global Regenerative Medicine Market Size, By Type, 2018 (In %)
  • Figure 24: Global Regenerative Medicine Market Size, By Type, 2024 (In %)
  • Figure 25: Global Cell Therapy Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
  • Figure 26: Global Cell Therapy Regenerative Medicine Market, By Value, Forecast, 2019-2024 (USD Million)
  • Figure 27: Global Gene Therapy Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
  • Figure 28: Global Gene Therapy Regenerative Medicine Market, By Value, Forecast, 2019-2024 (USD Million)
  • Figure 29: Global Tissue Engineered Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
  • Figure 30: Global Tissue Engineered Regenerative Medicine Market, By Value, Forecast, 2019-2024 (USD Million)
  • Figure 31: Market Opportunity Chart of global regenerative medicine Market - By Type, By Value (Year - 2024)
  • Figure 32: Global Regenerative Medicine Market Size, By Application, 2018 (%)
  • Figure 33: Global Regenerative Medicine Market Size, By Application, 2024F (%)
  • Figure 34: Global Regenerative Medicine Market Size, By Application, 2018 (In %)
  • Figure 35: Global Regenerative Medicine Market Size, By Application, 2024 (In %)
  • Figure 36: Global Orthopaedic & Dental Market, By Value, 2014-2018 (USD Million)
  • Figure 37: Global Orthopaedic & Dental Market, By Value, Forecast, 2019-2024 (USD Million)
  • Figure 38: Global Cardiology Market, By Value, 2014-2018 (USD Million)
  • Figure 39: Global Cardiology Market, By Value, Forecast, 2019-2024 (USD Million)
  • Figure 40: Global Wound Healing Market, By Value, Forecast, 2019-2024 (USD Million)
  • Figure 41: Global Wound Healing Market, By Value, Forecast, 2019-2024 (USD Million)
  • Figure 42: Global Metabolism & Inflammatory Market, By Value, 2014-2018 (USD Million)
  • Figure 43: Global Metabolism & Inflammatory Market, By Value, Forecast, 2019-2024 (USD Million)
  • Figure 44: Global Immunology & Oncology Market, By Value, 2014-2018 (USD Million)
  • Figure 45: Global Immunology & Oncology Market, By Value, Forecast, 2019-2024 (USD Million)
  • Figure 46: Global Others Market, By Value, 2014-2018 (USD Million)
  • Figure 47: Global Others Market, By Value, Forecast, 2019-2024 (USD Million)
  • Figure 48: Market Opportunity Chart of global regenerative medicine Market - By Application, By Value (Year - 2024)
  • Figure 49: Global Healthcare Landscape, By Select Region
  • Figure 50: Global Regenerative Medicine Market Size, By Region, 2018 (%)
  • Figure 51: Global Regenerative Medicine Market Size, By Region, 2024 (%)
  • Figure 52: North America Regenerative Medicine Market Size, By Value, 2014-2018 (USD Million)
  • Figure 53: North America Regenerative Medicine Market Size, By Value, Forecast, 2019-2024 (USD Million)
  • Figure 54: North America Diseases Outlook
  • Figure 55: United States health care expenditure per capita, (In USD)
  • Figure 56: Canada health care expenditure per capita (In USD)
  • Figure 57: North America population aged 65 and above, 2013-2018 (% of total)
  • Figure 58: Prevalence of musculoskeletal condition in North America, In million, 2013-2020E
  • Figure 59: Prevalence of skin diseases in North America, In million. 2013-202E
  • Figure 60: Prevalence of cardiovascular disease in North America, In million
  • Figure 61: North America GDP, 2012-2017 (USD Trillion)
  • Figure 62: North America GDP per capita, current prices, 2013-2023F (In USD)
  • Figure 63: North America Regenerative Medicine Market: Prominent Companies (2018)
  • Figure 64: North America Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
  • Figure 65: North America Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
  • Figure 66: North America Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
  • Figure 67: North America Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
  • Figure 68: North America Regenerative Medicine Market Size, By Country, 2018 (%)
  • Figure 69: North America Regenerative Medicine Market Size, By Country, 2024F (%)
  • Figure 70: Market Opportunity Chart of North America Regenerative Medicine Market - By Type, By Value (Year - 2024)
  • Figure 71: USA Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
  • Figure 72: USA Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
  • Figure 73: Clinical trials supported by CIRM, By Disease, In 2018
  • Figure 74: Percentage of adults aged 18-64 with insurance coverage in United States, By Poverty status, In 2018
  • Figure 75: Percentage of individuals with insurance coverage in United States, By Age Group, In 2018
  • Figure 76: Medical and Healthcare Research & Development Spending, 2014-2017 (In USD Million)
  • Figure 77: Research and Development Expenditure of total U.S. Pharmaceutical Industry, 2013-2017, (USD Billion)
  • Figure 78: NIH Funding For Stem Cell Research, 2015-2018 (In USD Million)
  • Figure 79: NIH Funding For Regenerative Medicine Research, 2015-2018 (In USD Million)
  • Figure 80: Prevalence of cardiovascular diseases in United States, In million
  • Figure 81: Prevalence of Wounds in United States, By Type, (Percentage of Total)
  • Figure 82: Percentage of people with chronic health conditions in United States
  • Figure 83: U.S. Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
  • Figure 84: U.S. Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
  • Figure 85: U.S. Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
  • Figure 86: U.S. Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
  • Figure 87: Canada Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
  • Figure 88: Canada Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
  • Figure 89: Canada, Expenditure on Health as a share of GDP, 2012-2017 (In %)
  • Figure 90: Canada, Per Capita Healthcare Expenditure, 2012-2017 (USD)
  • Figure 91: Healthcare Expenditure in Canada, By Source Breakdown, In USD million
  • Figure 92: Canada Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
  • Figure 93: Canada Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
  • Figure 94: Canada Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
  • Figure 95: Canada Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
  • Figure 96: Europe Regenerative Medicine Market Size, By Value, 2014-2018 (USD Million)
  • Figure 97: Europe Regenerative Medicine Market Size, By Value, Forecast, 2019-2024 (USD Million)
  • Figure 98: Regenerative Medicine in Clinical Trails, By Phase, 2018
  • Figure 99: Europe Health Expenditure, By Select Country, 2017 & 2045 (% of GDP)
  • Figure 100: Prevalence of Diabetes (Age 18+), 2017 & 2045E (In Million)
  • Figure 101: Diabetes Prevalence (% of population ages 20 to 79), By Select Country, 2017
  • Figure 102: European Union, Population ages 65 and above, 2013-2018 (% of total)
  • Figure 103: Per Capita Health Expenditure, By Select Country, 2018 (USD)
  • Figure 104: European Country Population Aged 65 and Above, 2012-2017 (% of Total)
  • Figure 105: GDP, Europe Region, By Select Country, 2017 (In Trillion USD)
  • Figure 106: Europe Regenerative Medicine Market: Leading Companies (2018)
  • Figure 107: Europe Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
  • Figure 108: Europe Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
  • Figure 109: Europe Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
  • Figure 110: Europe Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
  • Figure 111: Europe Regenerative Medicine Market Size, By Country, 2018 (%)
  • Figure 112: Europe Regenerative Medicine Market Size, By Country, 2024F (%)
  • Figure 113: Market Opportunity Chart of Europe Regenerative Medicine Market - By Type, By Value (Year - 2024)
  • Figure 114: U.K. Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
  • Figure 115: U.K. Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
  • Figure 116: U.K, Total Number of Biotech Companies, By Sector, 2017
  • Figure 117: U.K, Pharmaceutical R&D Spending, Euro Million, 2013-2016
  • Figure 118: Proportional mortality in United Kingdom, In 2018
  • Figure 119: Healthcare spending pattern in United Kingdom, In 2018
  • Figure 120: U.K, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
  • Figure 121: U.K, Population Ages 65 and Above (% of total), 2012-2018
  • Figure 122: U.K. Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
  • Figure 123: U.K. Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
  • Figure 124: U.K. Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
  • Figure 125: U.K. Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
  • Figure 127: Germany Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
  • Figure 128: Germany Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
  • Figure 129: German Biotechnology companies expenditure on R&D, In Million Euros
  • Figure 130: Prevalence of cardiovascular diseases in Germany, (In %)
  • Figure 131: Proportional mortality in Germany, In 2018
  • Figure 132: Healthcare spending pattern in Germany, In 2018, In USD
  • Figure 133: Health insurance coverage in Germany, In 2018
  • Figure 134: Germany, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
  • Figure 135: Germany, Population ages 65 and above, 2012-2018 (% total)
  • Figure 136: Germany Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
  • Figure 137: Germany Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
  • Figure 138: Germany Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
  • Figure 139: Germany Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
  • Figure 140: France Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
  • Figure 141: France Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
  • Figure 142: France, Number of Biotech Companies, By Type, 2017
  • Figure 143: France, Prevalence of Cancer, 2018, (% of total)
  • Figure 144: Prevalence of chronic diseases in France, In 2018
  • Figure 145: Proportional mortality in France, In 2018
  • Figure 146: Healthcare expenditure in France ( as a % of GDP)
  • Figure 147: Healthcare spending pattern in France, In 2016 & 2050, In USD
  • Figure 148: France Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
  • Figure 149: France Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
  • Figure 150: France Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
  • Figure 151: France Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
  • Figure 152: Italy Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
  • Figure 153: Italy Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
  • Figure 154: Prevalence of chronic diseases in Italy, In 2018
  • Figure 155: Prevalence of musculoskeletal condition in Italy, In million
  • Figure 156: Prevalence of Chronic respiratory diseases in Italy, In Million
  • Figure 157: Prevalence of cardiovascular diseases in Italy, In Thousands
  • Figure 158: Italy, Health Expenditure, (% of GDP), 2013-2017 (USD)
  • Figure 159: Italy, Population Ages 65 and Above (% of total), 2012-2018
  • Figure 160: Prevalence of skin diseases in Italy, In million
  • Figure 161: Italy, Spending on Healthcare, 2015 & 2040, (USD Per Person)
  • Figure 162: Italy Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
  • Figure 163: Italy Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
  • Figure 164: Italy Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
  • Figure 165: Italy Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
  • Figure 166: APAC Regenerative Medicine Market Size, By Value, 2014-2018 (USD Million)
  • Figure 167: APAC Regenerative Medicine Market Size, By Value, Forecast, 2019-2024 (USD Million)
  • Figure 168: APAC, GDP, By Select Country, 2017 (In USD Trillion)
  • Figure 169: Diabetes Prevalence (% of population ages 20 to 79), By Select Country, 2018
  • Figure 170: Obesity Rate, By Select Country, 2017 (In Percentage)
  • Figure 171: Prevalence of musculoskeletal condition in Asia, 2013-2020F, In million
  • Figure 172: Prevalence of chronic respiratory diseases in Asia, 2013-2020F, In million
  • Figure 173: Population ages 65 and above, APAC Region, By Select Countries, 2018 (% of total)
  • Figure 174: Population ages 65 and above, APAC Region, By Select Countries, 2050 (% of total)
  • Figure 175: APAC Regenerative Medicine Market: Leading Companies (2018)
  • Figure 176: APAC Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
  • Figure 177: APAC Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
  • Figure 178: APAC Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
  • Figure 179: APAC Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
  • Figure 180: APAC Regenerative Medicine Market Size, By Country, 2018 (%)
  • Figure 181: APAC Regenerative Medicine Market Size, By Country, 2024F (%)
  • Figure 182: Market Opportunity Chart of APAC Regenerative Medicine Market - By Type, By Value (Year - 2024)
  • Figure 183: India Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
  • Figure 184: India Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
  • Figure 185: India, Population ages 65 and above, 2013-2018, In Million
  • Figure 186: India, Share of Urban Population, 2012-2018 (In %)
  • Figure 187: Prevalence of musculoskeletal condition in India, 2013-2020E, In Million
  • Figure 188: Prevalence of chronic respiratory diseases in India, In Million
  • Figure 189: Prevalence of skin diseases in India, In Million
  • Figure 190: Prevalence of cardiovascular disease in India, In million
  • Figure 191: Growth of biotechnology industry in India
  • Figure 192: Healthcare expenditure pattern in India, 2016 & 2050, In USD $
  • Figure 193: Prevalence of non- communicable diseases in India, In 2018
  • Figure 194: India, GDP Growth Per Year, 2015-2019F (In %)
  • Figure 195: India, Total Population, 2013-2023F (In Million)
  • Figure 196: India Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
  • Figure 197: India Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
  • Figure 198: India Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
  • Figure 199: India Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
  • Figure 200: Japan Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
  • Figure 201: Japan Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
  • Figure 202: Japan Healthcare Expenditure Outlook (2017) (%)
  • Figure 203: Prevalence of diabetes in Japan, In million
  • Figure 204: Prevalence of cardiovascular disease in Japan, In million
  • Figure 205: Japan, Cancer Prevalence, By Type, (2018)
  • Figure 206: Proportional mortality in Japan, In 2018
  • Figure 207: Japan, GDP Growth Per Year, 2015-2019F (In %)
  • Figure 208: Japan, Population ages 65 and above, 2012-2018 (% of total)
  • Figure 209: Japan Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
  • Figure 210: Japan Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
  • Figure 211: Japan Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
  • Figure 212: Japan Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
  • Figure 213: China Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
  • Figure 214: China Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
  • Figure 215: Prevalence of cardiovascular disease in China, In million
  • Figure 216: Prevalence of diabetes in China, In million
  • Figure 217: China, Population ages 65 and above, 2012-2018 (% of total)
  • Figure 218: China Healthcare Expenditure Outlook (2018) (%)
  • Figure 219: China, GDP Growth Per Year, 2015-2019 (In %)
  • Figure 220: China, Share of Urban Population, 2012-2018 (In %)
  • Figure 221: China, Total Population, 2013-2021F (In Million)
  • Figure 222: China Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
  • Figure 223: China Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
  • Figure 224: China Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
  • Figure 225: China Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
  • Figure 226: ROW Regenerative Medicine Market Size, By Value, 2014-2018 (USD Million)
  • Figure 227: ROW Regenerative Medicine Market Size, By Value, Forecast, 2019-2024 (USD Million)
  • Figure 228: Cancer Prevalence in MENA (% of total), 2018
  • Figure 229: Cancer Prevalence in Latin America & Caribbean , (% of total), 2018
  • Figure 230: Population ages 65 and above, By Select Country, 2017 (% of total)
  • Figure 231: Population ages 60 or above, By Select Country, 2050 (% of total)
  • Figure 232: Prevalence of musculoskeletal condition in Middle East and North Africa, In USD million
  • Figure 233: Prevalence of chronic respiratory disease in Middle East and North Africa, In USD million
  • Figure 234: Latin America and Caribbean, Population ages 65 and above 2012-2018 (% of total)
  • Figure 235: Latin America and Caribbean, Share of Urban Population in Total Population, 2012-2018
  • Figure 236: Middle East and North Africa, Population ages 65 and above (% of total)
  • Figure 237: Middle East and North Africa, GDP, 2012-2018 (In USD Trillion)
  • Figure 238: Prevalence of diabetes in Latin America ad Caribbean, In million
  • Figure 239: Prevalence of diabetes in Middle East and North Africa, In million
  • Figure 240: ROW Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
  • Figure 241: ROW Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
  • Figure 242: ROW Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
  • Figure 243: ROW Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
  • Figure 244: ROW Regenerative Medicine Market Size, By Country, 2018 (%)
  • Figure 245: ROW Regenerative Medicine Market Size, By Country, 2024F (%)
  • Figure 246: Brazil Regenerative Medicine Market, By Value, 2014-2018 (USD Million)
  • Figure 247: Brazil Regenerative Medicine Market, By Value, 2019-2024 (USD Million)
  • Figure 248: Prevalence of diabetes in Brazil, In million
  • Figure 249: Prevalence of chronic respiratory diseases in Brazil, In million
  • Figure 250: Brazil, Population ages 65 and above, 2012-18 (% of total)
  • Figure 251: Brazil, GDP, 2012-2018 (In USD Trillion)
  • Figure 252: Prevalence of cardiovascular disease in Brazil, In Million
  • Figure 253: Brazil health expenditure as a share of GDP, 2018
  • Figure 254: Brazil Regenerative Medicine Market: By Type, By Value, 2014-2018 (USD Million)
  • Figure 255: Brazil Regenerative Medicine Market: By Type, By Value, 2019-2024 (USD Million)
  • Figure 256: Brazil Regenerative Medicine Market: By Application, By Value, 2014-2018 (USD Million)
  • Figure 257: Brazil Regenerative Medicine Market: By Application, By Value, 2019-2024 (USD Million)
  • Figure 258: Global Regenerative Medicine Market Share, By Select Company, 2018 (In %)
  • Figure 259: Global Regenerative Medicine Market - Pipeline Products, By Company
  • Figure 260: Global Regenerative Medicine Market - Pipeline Products, By Therapeutic area
  • Figure 261: Vericel, Sales Revenue, 2014-2018 (USD Million)
  • Figure 262: Vericel, MACI and Carticel Sales Revenue, 2014-2018 (USD Million)
  • Figure 263: Vericel, Epicel Sales Revenue, 2014-2018 (USD Million)
  • Figure 264: Gilead Sciences, Sales Revenue, 2014-2018 (USD Billion)
  • Figure 265: Novartis, Net Sales, 2014-2018 (In Billion USD)
  • Figure 266: Novartis, Sales, By Innovative Medicine Segment, FY ended March 2018 (%)
  • Figure 267: Novartis, Net Sales, By Geographic Region, 2018 (In %)
  • Figure 268: Spark Therapeutics, Sales Revenue, 2016-2018 (USD Billion)
  • Figure 269: Celgene Annual Sales Revenue, 2013-2017 (USD Billion)
  • Figure 270: Celgene, Sales, By Regenerative Segment, FY ended March 2017 (%)
  • Figure 271: Celgene, By Region, FY ended March 2017 (%)
  • Figure 272: Sanofi Annual Sales Revenue of Cardiac and Vascular Group,2014-2018 (USD Million)
  • Figure 273: Sanofi , Sales, By Business Segment, FY ended March 2018 (%)
  • Figure 274: Sanofi, By Region, FY ended March 2018 (%)
  • Figure 275: Amgen, Annual Sales Revenue, 2014-2018 (USD Billion)
  • Figure 276: Amgen, By Region, FY ended March 2018 (%)

List of Tables

Table A: Top 10 countries with enormous stem cell research

Table B: Diseases curable by hematopoietic stem cell transplant in United States, In 2018

Table C: Funding received by California Institute of regenerative medicine

Table D: Accredited family cord blood banks in United States , In 2018

Table E: Facts about cardiovascular diseases in United States, In 2018

Table F: Accredited family cord blood banks in Canada , In 2018

Table G: Research funding of Stem Cell Network, Canada , In 2018, In CAD $

Table H: Research funding sources of Ontario Institute of Regenerative Medicine, In 2018, In CAD $

Table I: Prevalence of chronic conditions in Canada, In 2018, In percentage

Table J: Legislative and Governance framework for stem cell research in Europe

Table K: Disease burden and death from non-communicable diseases in European Region, In 2017

Table L: Regenerative Medicine Financing , 2018

Table M: Facts about chronic disease in Europe

Table N: EU-5 Socio-Economical Statistics, 2018

Table O: Causes of chronic diseases

Table P: Prevailing risk factors for chronic disease in United Kingdom, In 2018, In %

Table Q: Accredited family cord blood banks in Germany, In 2018

Table R: Top 5 countries with number of diabetic people across Europe, In million, In 2017

Table S: Germany, Healthcare Related Statistics, 2017

Table T: Accredited family cord blood banks in Italy, In 2018

Table U: Accredited family cord blood banks in India, In 2018

Table V: Accredited family cord blood banks in China, In 2018

Table W: Top 10 causes of death in China, In 2018

Table X: Prevailing risk factors for chronic diseases across China, In 2018

Table Y: Accredited family cord blood banks in Brazil, In 2018

Table Z: Prevailing risk factors for Chronic diseases across Brazil, In 2018

Table AA: Healthcare spending pattern in Brazil (In USD)

Table AB: Recent Company Collaborations, Partnerships and Alliances in Regenerative medicine Market

Table AC: FDA approved cellular and gene therapy products

Table AD: Cell and Gene Therapy approved by European Medicines Agency

目次

Executive Summary

As stated by the research report published by Azoth Analytics in August 2019, the Global Regenerative Medicine Market was valued at USD 22,814.45 million the year 2018. Driven by a number of differentiated fundamental factors including rise in the prevalence of chronic diseases and increase in medical research investments, the global market for regenerative medicine has been advancing at an augmented pace. The growth has been primarily driven by the search to find permanent cure of large number of incurable diseases such as various autoimmune and metabolic ailments,

cancer, neurodegenerative disorders among others.

Over the recent years, regenerative medicine market has been witnessing considerable growth on the back of rising incidence of chronic diseases, rapidly growing medical research facilities, increasing investment by pharmaceutical manufacturers, and growing government initiatives. In addition, expanding product pipeline of companies and growing number of partnerships and collaborative agreements in this industry is anticipated to fuel the market growth in forecast period. However, high cost associated with the manufacturers and use of regenerative therapy has been hindering market growth.

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of regenerative medicine market. The report analyses the Global Regenerative Medicine Market By Type (Cell Therapy, Gene Therapy, Tissue Engineered) and By Application (Orthopaedic and Dental, Cardiology, Wound Healing, Metabolism and Inflammation, Immunology & Oncology, Others). The global regenerative medicine market has been analyzed By Region (North America, Europe, Asia Pacific, and ROW) and By Country (U.S., Canada, U.K., Germany, France, Italy, China, Japan, India, Brazil) for the historical period of 2014-2018 and the forecast period of 2019-2024.

Scope of the Report

Global Regenerative Medicine Market (Actual Period: 2014-2018, Forecast Period: 2019-2024)

  • Global Regenerative Medicine Market- Size, Growth, Forecast
  • Analysis By Type: Cell Therapy, Gene Therapy, Tissue Engineered.
  • Analysis By Application: Orthopaedic & Dental, Cardiology, Wound Healing, Metabolism & Inflammation, Immunology & Oncology, Others

Regional Regenerative Medicine Market - North America, Europe, Asia Pacific, ROW (Actual Period: 2014-2018, Forecast Period: 2019-2024)

  • Global Regenerative Medicine Market- Size, Growth, Forecast
  • Analysis By Type: Cell Therapy, Gene Therapy, Tissue Engineered.
  • Analysis By Application: Orthopaedic & Dental, Cardiology, Wound Healing, Metabolism & Inflammation, Immunology & Oncology, Others

Country Regenerative Medicine Market - U.S., Canada, Germany, U.K, France, Italy, China, Japan, India, and Brazil (Actual Period: 2014-2018, Forecast Period: 2019-2024)

  • Global Regenerative Medicine Market- Size, Growth, Forecast
  • Analysis By Type: Cell Therapy, Gene Therapy, Tissue Engineered.
  • Analysis By Application: Orthopaedic & Dental, Cardiology, Wound Healing, Metabolism & Inflammation, Immunology & Oncology, Others

Other Report Highlights

  • Competitive Landscape:
  • Company Share Analysis
  • Collaborations, Partnerships and Alliances between Key Industry Players
  • Approved Product Analysis
  • Product Pipeline Analysis
  • Market Dynamics - Drivers and Restraints.
  • Market Trends
  • Porter Five Forces Analysis.
  • SWOT Analysis.
  • Company Analysis - Vericel, Gilead Sciences, Novartis, Spark Therapeutics, Orchard Therapeutics, MolMed, Celgene, Sanofi, Amgen, Shanghai Sunway Biotech.

Customization of the Report

The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research.

Table of Contents

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Regenerative Medicine Market: Product Outlook

5. Global Regenerative Medicine Market : Growth and Forecast

  • 5.1 By Value (2014-2018)
  • 5.2 By Value (2019-2024)

6. Global Regenerative Medicine Market : Segment Analysis

  • 6.1 Global Regenerative Medicine Market Size, By Type: Breakdown (%)
    • 6.1.1 Global Regenerative Medicine Market Size, By Type, 2018 (%)
    • 6.1.2 Global Regenerative Medicine Market Size, By Type, 2024 (%)
  • 6.2 Global Cell Therapy Regenerative Medicine Market, By Value (2014-2024)
  • 6.3 Global Gene Therapy Regenerative Medicine Market, By Value (2014-2024)
  • 6.4 Global Tissue Engineered Regenerative Medicine Market, By Value (2014-2024)
  • 6.5 Market attractiveness of Global Regenerative Medicine Market- By Type
  • 6.6 Global Regenerative Medicine Market Size, By Application: Breakdown (%)
    • 6.6.1 Global Regenerative Medicine Market Size, By Application, 2018 (%)
    • 6.6.2 Global Regenerative Medicine Market Size, By Application, 2024 (%)
  • 6.7 Global Orthopaedic & Dental Regenerative Medicine Market, By Value (2014-2024)
  • 6.8 Global Cardiology Regenerative Medicine Market, By Value (2014-2024)
  • 6.9 Global Wound healing Regenerative Medicine Market, By Value (2014-2024)
  • 6.10 Global Metabolism & Inflammation Regenerative Medicine Market, By Value (2014-2024)
  • 6.11 Global Immunology & Oncology Regenerative Medicine Market, By Value (2014-2024)
  • 6.12 Global Others Regenerative Medicine Market, By Value (2014-2024)
  • 6.1 3 Market attractiveness of Global Regenerative Medicine Market- By Application

7.Global Regenerative Medicine Market : Regional Analysis

  • 7.1 Global Regenerative Medicine Market Size, By Region : Breakdown (%)
    • 7.1.1 Global Regenerative Medicine Market Size, By Region, 2018 (%)
    • 7.1.2 Global Regenerative Medicine Market Size, By Region, 2024 (%)
  • 7.2 North America Regenerative Medicine Market: Growth and Forecast
    • 7.2.1 By Value (2014-2018)
    • 7.2.2 By Value (2019-2024)
    • 7.2.3 North America Regenerative Medicine Market: Competitive Landscape
    • 7.2.4 By Type, By Value (2014-2018)
    • 7.2.5 By Type, By Value (2019-2024)
    • 7.2.6 By Application, By Value (2014-2018)
    • 7.2.7 By Application, By Value (2019-2024)
  • 7.3 North America Regenerative Medicine Market: Country Analysis (U.S and Canada)
  • 7.4 Market Attractiveness of North America Regenerative Medicine Market- By Country
    • 7.4.1 U.S Regenerative Medicine Market, By Value (2014-2024)
    • 7.4.2 U.S Regenerative Medicine Market, By Type, By Value (2014-2018)
    • 7.4.3 U.S Regenerative Medicine Market, By Type, By Value (2019-2024)
    • 7.4.4 U.S Regenerative Medicine Market, By Application, By Value (2014-2018)
  • 7.4. 5U.S Regenerative Medicine Market, By Application, By Value (2019-2024)
    • 7.4.6 Canada Regenerative Medicine Market, By Value (2014-2024)
    • 7.4.7 Canada Regenerative Medicine Market, By Type, By Value (2014-2018)
    • 7.4.8 Canada Regenerative Medicine Market, By Type, By Value (2019-2024)
    • 7.4.9 Canada Regenerative Medicine Market, By Application, By Value (2014-2018)
    • 7.4.10 Canada Regenerative Medicine Market, By Application, By Value (2019-2024)
  • 7.5 Europe Regenerative Medicine Market: Growth and Forecast
    • 7.5.1 By Value (2014-2018)
    • 7.5.2 By Value (2019-2024)
    • 7.5.3 Europe Regenerative Medicine Market: Competitive Landscape
    • 7.5.4 By Type, By Value (2014-2018)
    • 7.5.5 By Type, By Value (2019-2024)
    • 7.5.6 By Application, By Value (2014-2018)
    • 7.5.7 By Application, By Value (2019-2024)
  • 7.6 Europe Regenerative Medicine Market: Country Analysis (U.K ,Germany, France, Italy)
  • 7.7 Market Attractiveness of Europe Regenerative Medicine Market- By Country
    • 7.7.1 U.K Regenerative Medicine Market, By Value (2014-2024)
    • 7.7.2 U.K Regenerative Medicine Market, By Type, By Value (2014-2018)
    • 7.7.3 U.K Regenerative Medicine Market, By Type, By Value (2019-2024)
    • 7.7.4 U.K Regenerative Medicine Market, By Application, By Value (2014-2018)
    • 7.7.5 U.K Regenerative Medicine Market, By Application, By Value (2019-2024)
    • 7.5.6 Germany Regenerative Medicine Market, By Value (2014-2024)
    • 7.5.7 Germany Regenerative Medicine Market, By Type, By Value (2014-2018)
    • 7.5.8 Germany Regenerative Medicine Market, By Type, By Value (2019-2024)
    • 7.5.9 Germany Regenerative Medicine Market, By Application, By Value (2014-2018)
    • 7.5.10 Germany Regenerative Medicine Market, By Application, By Value (2019-2024)
    • 7.5.11 France Regenerative Medicine Market, By Value (2014-2024)
    • 7.5.12 France Regenerative Medicine Market, By Type, By Value (2014-2018)
    • 7.5.13 France Regenerative Medicine Market, By Type, By Value (2019-2024)
    • 7.5.14 France Regenerative Medicine Market, By Application, By Value (2014-2018)
    • 7.5.15 France Regenerative Medicine Market, By Application, By Value (2019-2024)
    • 7.5.16 Italy Regenerative Medicine Market, By Value (2014-2024)
    • 7.5.17 Italy Regenerative Medicine Market, By Type, By Value (2014-2018)
    • 7.5.18 Italy Regenerative Medicine Market, By Type, By Value (2019-2024)
    • 7.5.19 Italy Regenerative Medicine Market, By Application, By Value (2014-2018)
    • 7.5.20 Italy Regenerative Medicine Market, By Application, By Value (2019-2024)
  • 7.6 APAC Regenerative Medicine Market: Growth and Forecast
    • 7.6.1 By Value (2014-2018)
    • 7.6.2 By Value (2019-2024)
    • 7.6.3 APAC Regenerative Medicine Market: Competitive Landscape
    • 7.6.4 By Type, By Value (2014-2018)
    • 7.6.5 By Type, By Value (2019-2024)
    • 7.6.6 By Application, By Value (2014-2018)

7.6.7By Application, By Value (2019-2024)

  • 7.7 APAC Regenerative Medicine Market: Country Analysis (Japan, India, China)
  • 7.8 Market Attractiveness of APAC Regenerative Medicine Market- By Country
    • 7.8.1 India Regenerative Medicine Market, By Value (2014-2024)
    • 7.8.2 India Regenerative Medicine Market, By Type, By Value (2014-2018)
    • 7.8.3 India Regenerative Medicine Market, By Type, By Value (2019-2024)
    • 7.8.4 India Regenerative Medicine Market, By Application, By Value (2014-2018)
    • 7.8.5 India Regenerative Medicine Market, By Application, By Value (2019-2024)
    • 7.8.6 Japan Regenerative Medicine Market, By Value (2014-2024)
    • 7.8.7 Japan Regenerative Medicine Market, By Type, By Value (2014-2018)
    • 7.8.8 Japan Regenerative Medicine Market, By Type, By Value (2019-2024)
    • 7.8.9 Japan Regenerative Medicine Market, By Application, By Value (2014-2018)
    • 7.8.10 Japan Regenerative Medicine Market, By Application, By Value (2019-2024)
    • 7.8.11 China Regenerative Medicine Market, By Value (2014-2024)
    • 7.8.12 China Regenerative Medicine Market, By Type, By Value (2014-2018)
    • 7.8.13 China Regenerative Medicine Market, By Type, By Value (2019-2024)
    • 7.8.14 China Regenerative Medicine Market, By Application, By Value (2014-2018)
    • 7.8.15 China Regenerative Medicine Market, By Application, By Value (2019-2024)
  • 7.9 ROW Regenerative Medicine Market: Growth and Forecast
    • 7.9.1 By Value (2014-2018)
    • 7.9.2 By Value (2019-2024)
    • 7.9.4 By Type, By Value (2014-2018)
    • 7.9.5 By Type, By Value (2019-2024)
    • 7.9.6 By Application, By Value (2014-2018)
    • 7.9.7 By Application, By Value (2019-2024)
    • 7.9.8 ROW Regenerative Medicine Market: Country Analysis (Brazil)
    • 7.9.9 Brazil Regenerative Medicine Market, By Value (2014-2024)
    • 7.9.10 Brazil Regenerative Medicine Market, By Type, By Value (2014-2018)
    • 7.9.11 Brazil Regenerative Medicine Market, By Type, By Value (2019-2024)
    • 7.9.12 Brazil Regenerative Medicine Market, By Application, By Value (2014-2018)
    • 7.9.13 Brazil Regenerative Medicine Market, By Application, By Value (2019-2024)

8. Global Regenerative Medicine Market: Competitive Landscape

  • 8.1 Market share of Leading Global Companies
  • 8.2 Global Regenerative Medicine Market : Collaborations, Partnerships and Alliances
  • 8.3 Global Regenerative Medicine Market: Approved Products
  • 8.4 Global Regenerative Medicine Market: Pipeline Products

9. Global Regenerative Medicine Market Dynamics

  • 9.1 Global Regenerative Medicine Market Drivers
    • 9.1.1 Rapid Medical Research Infrastructure Development
    • 9.1.2 Increase in prevalence of chronic and autoimmune diseases
    • 9.1.3 Growing government expenditure in regenerative medicine research
  • 9.2 Global Regenerative Medicine Market Restraints
    • 9.2.1 High cost associated with regenerative medicines
  • 9.3 Global Regenerative Medicine Market Trend
    • 9.3.1 Emerging CAR-T cell therapy
    • 9.3.2 3-D Bioprinting of tissues and organs

10.Porter Five Force Analysis

11.SWOT Analysis

12.Policy and Regulatory Landscape

13.Company Profiles

  • 13.1 Vericel Corporation
  • 13.2 Gilead Sciences
  • 13.3 Novartis
  • 13.4 Spark Therapeutics
  • 13.5 Orchard Therapeutics
  • 13.6 Shanghai Sunway Biotech Co. Ltd.
  • 13.7 MolMed
  • 13.8 Celgene
  • 13.9 Sanofi
  • 13.10 Amgen
Back to Top